The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

AGY ALLERGY THERAPEUTICS PLC ORD 0.1P




 Page 2 of 2

Previous | 1 | 2 |

Time/Date Code Headline Source Impact
07:00 21-Sep-2015 AGY Final Results RNS +0.57% Up
07:04 01-Sep-2015 AGY First patient recruited in PQ Birch dose study RNS +4.34% Up
07:00 10-Aug-2015 AGY Key paper published in the World Allergy Journal RNS -0.83% Down
07:00 27-Jul-2015 AGY Director Share Dealings RNS +13.95% Up
07:00 23-Jul-2015 AGY Notice of Results and Trading Update RNS +11.91% Up
07:00 06-Jul-2015 AGY Positive Dust Mite Study Results RNS +2.52% Up
07:00 02-Jul-2015 AGY Company to Host Key Allergy Conference RNS +5.74% Up
07:00 25-Jun-2015 AGY Company to resume US clinical programme RNS +7.63% Up
10:59 05-Jun-2015 AGY Acquisition of Alerpharma S.A. RNS -1.42% Down

 Page 2 of 2

Previous | 1 | 2 |



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Market

Company Information
Updated Monthly
Company address Dominion Way, Worthing, BN14 8SA, United Kingdom
Company website http://www.allergythera...
Market cap(in millions)* £ 150.38
Listing/Admission to trading 11 Oct 2004
Trading service SEAQ
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
05-May-16
FTSE index FTSE AIM All-Share,FTSE AIM 100,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment AIM
MiFID Status MTF
Exchange market size 10,000
SEDOL B02LCQ0
ISIN number GB00B02LCQ05


Start trading your favourite asset CFDs!
Carries risk of capital loss



ALLERGY THERA. share news analysis (AGY)